SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 15th, 2020 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of ____ __, 2020, between Zomedica Pharmaceuticals Corp., an Alberta corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • May 15th, 2020 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • New York
SERIES C COMMON SHARE PURCHASE WARRANT Zomedica Pharmaceuticals Corp.Zomedica Pharmaceuticals Corp. • May 15th, 2020 • Pharmaceutical preparations • New York
THIS SERIES C COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _________ __, 2025 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Zomedica Pharmaceuticals Corp., an Alberta corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common shares (the “Common Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is one of a series of similar warrants (collectively, the “Warrants”) issued by the Company pursuant to its Registration Statement on Form S-1 (file no. 333-___________) and the rela
